Clinical trial · Interventional
HPV Self-sampling in the General Population
HPV Self-sampling in the General Population: Efficacy, Feasibility, Acceptability and Cost-effectiveness
NCT06749847CI-TRIAL-00092468MIRABELLErecruitingN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
A randomized controlled trial comparing three strategies for cervical cancer screening: direct mailing of HPV self-sampling kit ("Outreach" arm), choice between self-sampling or healthcare provider sampling ("Choice" arm), and standard care (control arm) in two French departments.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cervical Cancer | Malignant Cervical Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Women receive invitation letter with choice of ordering a free self-sampling kit or visit healthcare provider | Other | — | UNRESOLVED |
| Women receive invitation letter with HPV self-sampling kit | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (3)
- type
- EXPERIMENTAL
- label
- Outreach
- description
- Women receive invitation letter with HPV self-sampling kit; Direct mailing of HPV self-sampling kit; Women receive HPV self-sampling kit with instructions; SMS reminder at 3 months if no participation; Assistance provided for triage cytology if HPV positive.
- interventionNames
- Other: Women receive invitation letter with HPV self-sampling kit
- type
- EXPERIMENTAL
- label
- Choice
- description
- Women receive an invitation letter offering a choice between ordering a free self-sampling kit or visiting a healthcare provider. Option between self-sampling and healthcare provider: women can choose testing method. If self-sampling chosen, kit sent to home. SMS reminder at 3 months if no participation.
- interventionNames
- Other: Women receive invitation letter with choice of ordering a free self-sampling kit or visit healthcare provider
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 30 Years
- Maximum age
- 65 Years
Show eligibility criteria text
Inclusion Criteria: * Women aged 30 to 65 years old * Living in the study area (Departments of Marne and Aube, France) * At moderate risk of cervical cancer, i.e. eligible to the organised programme and receiving the first invitation of the screening round (not a reminder letter) Exclusion Criteria: * Outside the target age (less than 30 years old, or 66 years old and more) * Already participating in the current screening round * Total hysterectomy * History of cervical cancer * Current follow-up for abnormal cervical screening result or cervical lesions
References
Publications (0)
Data not yet available
No reference posted for this study.